The Biden administration recently proposed misinterpreting a decades-old law to try to lower drug prices. But as multiple studies have already shown, the White House's plan would do nothing to achieve that goal. By Walter G. Copan, Ph.D. Instead, it risks destroying our nation's capacity for innovation across every high-tech sector by eliminating incentives for […]
This post COMMENTARY - Collateral Damage: U.S. Innovation appeared first on The Orlando Advocate.
